Unpublished Clinical Trial Data of MS Drug Alemtuzumab Concerning

News   Jun 16, 2017 | Original Story from Queen Mary's University London

 
Previously Unpublished Clinical Trial Data Explain Effects and Issues of Key MS Drug
 
 
 
 

RELATED ARTICLES

360 New Disease Models Identified in Lab Mouse Study

News

The research, which generated over 20 million pieces of data, has found 360 new disease models and provides 28,406 new descriptions of the genes’ effects on mouse biology and disease.

READ MORE

LifeArc, Dstl and CDRD Collaborate to Identify Antibacterial Drug Targets

News

Novel approach capitalises on commonality across pathogens.

READ MORE

FDA to Fast Track Designation for Pfizer and Lilly's Tanezumab

News

Global Phase 3 program is studying potential new treatment option for millions of people living with chronic pain associated with osteoarthritis and chronic low back pain.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science Drug Discovery Neuroscience

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE